About
Platelet Stabilization Technology
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
262
By Phase
PHASE2: 2PHASE2/PHASE3: 1PHASE1: 1EARLY_PHASE1: 1
By Status
COMPLETED: 4TERMINATED: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05771831Collaborator
Thrombosomes® in Acute Thoracic Aortic Dissections
PHASE2Completed
41 participants
Started: Mar 15, 2023 · Completed: Apr 11, 2024
NCT04709705Lead Sponsor
DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)
PHASE2/PHASE3Completed
161 participants
Started: Oct 27, 2021 · Completed: May 8, 2025
NCT04631211Lead Sponsor
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
PHASE2Terminated
21 participants
Started: Mar 5, 2021 · Completed: Jan 7, 2022
NCT03394755Lead Sponsor
Thrombosomes® in Bleeding Thrombocytopenic Patients
PHASE1Completed
24 participants
Started: Mar 19, 2018 · Completed: Sep 25, 2019
NCT02223117Lead Sponsor
Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)
EARLY_PHASE1Completed
15 participants
Started: Sep 30, 2014 · Completed: Jul 21, 2016
Locations (1)
Headquarters
Rockville, MD, United States
Map
Loading map...